Evidence map›Paper›PMID 19880512›Full record

ArticleThe Journal of biological chemistry2009

RNA interference in Trypanosoma brucei: role of the n-terminal RGG domain and the polyribosome association of argonaute.

Huafang Shi, Nathalie Chamond, Appolinaire Djikeng, Christian Tschudi, Elisabetta Ullu

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Mutations in PpAGO3 Lead to Enhanced Virulence ofFrontiers in microbiology · 2022
    Article
  3. A systematic analysis ofGenome research · 2021
    Article
  4. Article
  5. The evolutionary journey of Argonaute proteins.Nature structural & molecular biology · 2014
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Huafang ShiDepartment of Internal Medicine, Yale University Medical School, New Haven, Connecticut 06536-8012.
Nathalie ChamondDepartment of Internal Medicine, Yale University Medical School, New Haven, Connecticut 06536-8012.
Appolinaire DjikengDepartment of Internal Medicine, Yale University Medical School, New Haven, Connecticut 06536-8012.
Christian TschudiDepartment of Epidemiology and Public Health, Yale University Medical School, New Haven, Connecticut 06536-8012. Electronic address: christian.tschudi@yale.edu.
Elisabetta UlluDepartment of Internal Medicine, Yale University Medical School, New Haven, Connecticut 06536-8012; Department of Cell Biology, Yale University Medical School, New Haven, Connecticut 06536-8012.
Yale University · US

Funding

TRANSCRIPTION AND RNA PROCESSING IN TRYPANOSOMESR01AI028798 · NIAID · YALE UNIVERSITY · PI TSCHUDI, CHRISTIAN · 1990 to 2020
$10.9M
RNA CAPPING IN TRYPANOSOMESR01AI043594 · NIAID · YALE UNIVERSITY · PI TSCHUDI, CHRISTIAN · 1998 to 2012
$4.5M
RNA METABOLISM IN TRYPANOSOMESR37AI028798 · NIAID · YALE UNIVERSITY · PI ULLU, ELISABETTA · 2010 to 2013
$2.9M
NIAID NIH HHS AI28798NIAID NIH HHS AI43594NIAID NIH HHS R01 AI028798NIAID NIH HHS R01 AI043594NIAID NIH HHS R37 AI028798
6 · The paper itself

Abstract

Argonaute proteins (AGOs) are central to RNA interference (RNAi) and related silencing pathways. At the core of the RNAi pathway in the ancient parasitic eukaryote Trypanosoma brucei is a single Argonaute protein, TbAGO1, with an established role in the destruction of potentially harmful retroposon transcripts. One notable feature of TbAGO1 is that a fraction sediments with polyribosomes, and this association is facilitated by an arginine/glycine-rich domain (RGG domain) at the N terminus of the protein. Here we report that reducing the size of the RGG domain and, in particular, mutating all arginine residues severely reduced the association of TbAGO1 with polyribosomes and RNAi-induced cleavage of mRNA. However, these mutations did not change the cellular localization of Argonaute and did not affect the accumulation of single-stranded siRNAs, an essential step in the activation of the RNA-induced silencing complex. We further show that mRNA on polyribosomes can be targeted for degradation, although this alliance is not a pre-requisite. Finally, sequestering tubulin mRNAs from translation with antisense morpholino oligonucleotides reduced the RNAi response indicating that mRNAs not engaged in translation may be less accessible to the RNAi machinery. We conclude that the association of the RNAi machinery and target mRNA on polyribosomes promotes an efficient RNAi response. This mechanism may represent an ancient adaptation to ensure that retroposon transcripts are efficiently destroyed, if they become associated with the translational apparatus.

Indexed as

Argonaute ProteinsPolyribosomesProtein Structure, TertiaryProtozoan ProteinsRetroelementsRNA-Binding ProteinsRNA InterferenceRNA, MessengerRNA, ProtozoanTrypanosoma brucei bruceiAGO1 protein, Trypanosoma bruceiArgonaute ProteinsProtozoan ProteinsRetroelementsRNA-Binding ProteinsRNA, MessengerRNA, Protozoan

Identifiers

PMID19880512
PMCPMC2794767
OpenAlexW2031559484

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.